SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-024510
Filing Date
2019-10-01
Accepted
2019-10-01 19:45:19
Documents
2
Period of Report
2019-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 17030
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2614
  Complete submission text file 0000899243-19-024510.txt   21239
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 455 MISSION BAY BOULEVARD SOUTH C/O NEKTAR THERAPEUTICS SAN FRANCISCO CA 94158
Business Address
Zalevsky Jonathan (Reporting) CIK: 0001789857 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24006 | Film No.: 191130533